RITUXIMAB AND HYALURONIDASE

453 reported adverse events

Drug classes: CD20-directed Cytolytic Antibody [EPC] Endoglycosidase [EPC]

These side effects are most commonly reported by patients taking RITUXIMAB AND HYALURONIDASE:

# Side effect Count
0 NO ADVERSE EVENT 88
1 OFF LABEL USE 82
2 RASH 50
3 FATIGUE 36
4 NAUSEA 35
5 PAIN 33
6 HEADACHE 28
7 DIZZINESS 27
8 PNEUMONIA 27
9 DYSPNOEA 26
See all common reactions for RITUXIMAB AND HYALURONIDASE

RITUXIMAB AND HYALURONIDASE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 PORPHYRIA ACUTE 17 0.0118
1 RETINITIS 15 0.0087
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 16 0.0080
3 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
4 DISLOCATION OF VERTEBRA 13 0.0057
5 BONE EROSION 16 0.0045
6 PERIPHERAL VENOUS DISEASE 16 0.0039
7 BREAST CANCER STAGE III 18 0.0028
8 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 16 0.0025
9 DUODENAL ULCER PERFORATION 17 0.0023
See all enriched reactions for RITUXIMAB AND HYALURONIDASE